Salt Lake City, October 4, 2001 -- Myriad Genetics, Inc. (NASDAQ: MYGN) and the University of Utah today announced the publication of the results of pioneering research into molecular mechanisms ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

A new kind of AIDS drug, which interrupts the last of the six stages in the life-cycle of HIV, has cleared the initial hurdle of clinical development, its developer said on Wednesday. Privately held U ...

Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human ...